In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerly Florida Blood Services) with three laboratories located in Dallas, Phoenix and Tampa. CTS test 4.3 million blood donations or approximately 25 percent of the U.S. blood supply.
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROSĀ® testing platform to perform COVID-1...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...